Northwest Biotherapeutics
Biotechnology company receives patent for antibodies to cancer protein
Published in Genetics and Environmental Health Week, April 20th, 2005
The protein, known as CXCR4, is a chemokine receptor, which is over expressed in more than 65% of human cancers, including breast, ovarian, lung, colon, prostate, kidney, melanoma, brain, esophageal, pancreatic, and many forms of leukemia, and childhood cancers such as acute lymphocytic leukemia and neuroblastoma.
The patent issued is United States patent No. 6,863,887, "Therapeutic and Diagnostic Applications Based on the Role of the CXCR4 Gene in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
More Articles from Genetics and Environmental Health Week
- ALK-Abello
Researchers show immune mechanisms after SLIT treatment - ASL RME, Rome
Pregnancy and maternal atopy may be associated, but it's unclear how - Aga Khan University, Pakistan
Hospital-acquired infections major problem for infants in developing countries - Altana AG
Alvesco provides relief of asthma symptoms comparable to budesonide, fluticasone - American Academy of Allergy, Asthma and Immunology
Budesonide nasal washing may decrease symptoms in chronic hyperplasic sinusitis - American Academy of Allergy, Asthma and Immunology
Differences in IgE levels found between parents and their children - More from this issue of Genetics and Environmental Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
